– published in Journal of Ayurveda and Integrative Medicine
Summary
Ethics vs. Evidence: Reconsidering the Global Regulation of Ashwagandha
An international controversy is brewing! Denmark’s move to ban the revered Ayurvedic herb Ashwagandha (Indian Ginseng) has sparked scientific alarm. This powerful analysis meticulously dismantles the flawed, non-peer-reviewed report behind the ban, revealing how it ignores centuries of safe traditional use and robust clinical evidence of safety and health benefits. Read why this potentially misleading decision sets a dangerous precedent, and why regulators worldwide must prioritize scientific truth over poor analysis!